|
Status |
Public on Nov 27, 2013 |
Title |
Expression data from a reversible dasatinib-resistant state in long-term dasatinib-treated c-KIT-mutated Kasumi-1 cell line |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Long-term treatment of Kasumi-1 cells at clinically attained doses of dasatinib led to decreased drug-sensitivity by means of IC50 values (relative to treatment-naive cells). Changes were paralled by profound alterations in c-KIT expression and cell signaling signatures. Upon brief discontinuation of dasatinib treatment, these alterations reversed and drug sensitivity was restored. We used gene expression profiling to examine reversal of dasatinib-resistance at the molecular/expression level.
|
|
|
Overall design |
Kasumi-1 cells were either treated with dasatinib for 12 weeks (R48) or left untreated (K). Subsequently, dasatinib was withdrawn from R48 cells for 1 week (PR48). RNA was extracted from R48 and K cells and hybridized on Affymetrix microarrays after 12 weeks and PR48 after a total time span of 13 weeks.
|
|
|
Contributor(s) |
Holzmann K, Herrmann MD |
Citation(s) |
24211243 |
|
Submission date |
Jul 03, 2012 |
Last update date |
Jul 26, 2018 |
Contact name |
Karlheinz Holzmann |
E-mail(s) |
karlheinz.holzmann@uni-ulm.de
|
Organization name |
Ulm University
|
Department |
Medical Faculty
|
Lab |
Genomics Core Facility
|
Street address |
Helmholtzstreet 8/1
|
City |
Ulm |
ZIP/Postal code |
D-89081 |
Country |
Germany |
|
|
Platforms (1) |
GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
|
Samples (9)
|
|
Relations |
BioProject |
PRJNA169900 |